3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
29
Recruiting
19
Unknown
13
Terminated
8
Active not recruiting
5
Withdrawn
2
Not yet recruiting
1
Sponsor Class
INDUSTRY
2
OTHER_GOV
1
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Breast Neoplasms
468
Neoplasms
332
Colorectal Neoplasms
235
Carcinoma, Non-Small-Cell Lung
235
Lung Neoplasms
200
Prostatic Neoplasms
182
Carcinoma, Hepatocellular
175
Stomach Neoplasms
138
Pancreatic Neoplasms
126
Leukemia, Myeloid, Acute
115
Uterine Cervical Neoplasms
111
Rectal Neoplasms
103
Multiple Myeloma
94
Recurrence
89
Squamous Cell Carcinoma of Head and Neck
84
Head and Neck Neoplasms
80
Ovarian Neoplasms
78
Neoplasm Metastasis
77
Brain Neoplasms
71
Colonic Neoplasms
68
Glioblastoma
67
Esophageal Neoplasms
66
Triple Negative Breast Neoplasms
64
Endometrial Neoplasms
61
Small Cell Lung Carcinoma
55
Precursor Cell Lymphoblastic Leukemia-Lymphoma
55
Motor Activity
54
Hematologic Neoplasms
54
Disease
54
Glioma
48
Interventions
trametinib
1
dabrafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
OTHER
×
Neoplasms by Site
×
Clear all
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled